Clinical trial
A Study of ABT-751 in Patients With Renal Cell Cancer
NCT00073112 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00073112 |
|---|---|
| Title | A Study of ABT-751 in Patients With Renal Cell Cancer |
| Official title | A Phase 2 Study of ABT-751 in Subjects With Refractory Colorectal Carcinoma |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Renal Cell Cancer |
| Intervention type | Drug |
| Interventions | ABT-751 |
| Enrollment | 60 |
| Start date | Aug 1, 2003 |
| Completion | Sep 1, 2006 |
| First posted | Nov 18, 2003 |
| Last update posted | Nov 29, 2007 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: